360 related articles for article (PubMed ID: 25277271)
1. A genome-wide pleiotropy scan for prostate cancer risk.
Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Amin Al Olama A; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TL; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Dörk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang HW; Lu YJ; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Røder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin HY; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao GW; Slavov C; Mitev V; ; ; ; ; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
Hum Mol Genet; 2013 Jan; 22(2):408-15. PubMed ID: 23065704
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease.
Teerlink CC; Thibodeau SN; McDonnell SK; Schaid DJ; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Fitzgerald LM; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Wahlfors T; Tammela T; Schleutker J; Wiklund F; Grönberg H; Emanuelsson M; Carpten J; Bailey-Wilson J; Whittemore AS; Oakley-Girvan I; Hsieh CL; Catalona WJ; Zheng SL; Jin G; Lu L; Xu J; ; Camp NJ; Cannon-Albright LA
Hum Genet; 2014 Mar; 133(3):347-56. PubMed ID: 24162621
[TBL] [Abstract][Full Text] [Related]
4. Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.
Dimitrakopoulou VI; Travis RC; Shui IM; Mondul A; Albanes D; Virtamo J; Agudo A; Boeing H; Bueno-de-Mesquita HB; Gunter MJ; Johansson M; Khaw KT; Overvad K; Palli D; Trichopoulou A; Giovannucci E; Hunter DJ; Lindström S; Willett W; Gaziano JM; Stampfer M; Berg C; Berndt SI; Black A; Hoover RN; Kraft P; Key TJ; Tsilidis KK
Am J Epidemiol; 2017 Mar; 185(6):452-464. PubMed ID: 28399564
[TBL] [Abstract][Full Text] [Related]
5. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.
Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
[TBL] [Abstract][Full Text] [Related]
9. Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Lindström S; Schumacher FR; Campa D; Albanes D; Andriole G; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Diver WR; Ganziano JM; Gapstur SM; Giovannucci E; Haiman CA; Henderson B; Hunter DJ; Johansson M; Kolonel LN; Le Marchand L; Ma J; Stampfer M; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Yeager M; Hsing AW; Kraft P
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):212-6. PubMed ID: 22056501
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).
Markt SC; Shui IM; Unger RH; Urun Y; Berg CD; Black A; Brennan P; Bueno-de-Mesquita HB; Gapstur SM; Giovannucci E; Haiman C; Henderson B; Hoover RN; Hunter DJ; Key TJ; Khaw KT; Canzian F; Larranga N; Le Marchand L; Ma J; Naccarati A; Siddiq A; Stampfer MJ; Stattin P; Stevens VL; Stram DO; Tjønneland A; Travis RC; Trichopoulos D; Ziegler RG; Lindstrom S; Kraft P; Mucci LA; Choueiri TK; Wilson KM
Prostate; 2015 Nov; 75(15):1677-81. PubMed ID: 26268879
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
[TBL] [Abstract][Full Text] [Related]
12. Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?
Pinto AR; Silva J; Pinto R; Medeiros R
Pharmacogenomics; 2020 May; 21(7):487-503. PubMed ID: 32343194
[TBL] [Abstract][Full Text] [Related]
13. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
[TBL] [Abstract][Full Text] [Related]
14. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jin G; Lu L; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Cannon-Albright LA; Camp NJ; Teerlink CC; Fitzgerald LM; Stanford JL; Wiley KE; Isaacs SD; Walsh PC; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Thibodeau SN; McDonnell SK; Schaid DJ; Wiklund F; Grönberg H; Emanuelsson M; Whittemore AS; Oakley-Girvan I; Hsieh CL; Wahlfors T; Tammela T; Schleutker J; Catalona WJ; Zheng SL; Ostrander EA; Isaacs WB; Xu J;
Hum Genet; 2012 Jul; 131(7):1095-103. PubMed ID: 22198737
[TBL] [Abstract][Full Text] [Related]
15. A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.
Marzec J; Mao X; Li M; Wang M; Feng N; Gou X; Wang G; Sun Z; Xu J; Xu H; Zhang X; Zhao SC; Ren G; Yu Y; Wu Y; Wu J; Xue Y; Zhou B; Zhang Y; Xu X; Li J; He W; Benlloch S; Ross-Adams H; Chen L; Li J; Hong Y; Kote-Jarai Z; Cui X; Hou J; Guo J; Xu L; Yin C; Zhou Y; Neal DE; Oliver T; Cao G; Zhang Z; Easton DF; Chelala C; ; ; Al Olama AA; Eeles RA; Zhang H; Lu YJ
Oncotarget; 2016 Apr; 7(16):21393-403. PubMed ID: 26881390
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.
Na R; Liu F; Zhang P; Ye D; Xu C; Shao Q; Qi J; Wang X; Chen Z; Wang M; He D; Wang Z; Zhou F; Yuan J; Gao X; Wei Q; Yang J; Jiao Y; Ou-Yang J; Zhu Y; Wu Q; Chen H; Lu D; Shi R; Lin X; Jiang H; Wang Z; Jiang D; Sun J; Zheng SL; Ding Q; Mo Z; Sun Y; Xu J
Prostate; 2013 Nov; 73(15):1623-35. PubMed ID: 24038036
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.
Campa D; Barrdahl M; Tsilidis KK; Severi G; Diver WR; Siddiq A; Chanock S; Hoover RN; Ziegler RG; Berg CD; Buys SS; Haiman CA; Henderson BE; Schumacher FR; Le Marchand L; Flesch-Janys D; Lindström S; Hunter DJ; Hankinson SE; Willett WC; Kraft P; Cox DG; Khaw KT; Tjønneland A; Dossus L; Trichopoulos D; Panico S; van Gils CH; Weiderpass E; Barricarte A; Sund M; Gaudet MM; Giles G; Southey M; Baglietto L; Chang-Claude J; Kaaks R; Canzian F
PLoS One; 2014; 9(2):e85955. PubMed ID: 24523857
[TBL] [Abstract][Full Text] [Related]
19. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
[TBL] [Abstract][Full Text] [Related]
20. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
